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Introduction:
In the production of transgenic animals, one of the most common methods employed is

the microinjection of DNA into the pronucleus of the embryo. This method was used to produce
the first transgenic animal, a mouse (Gordon et al., 1981). Five years later, the first transgenic
farm animal experiments were conducted. These studies involved the insertion of genes into pigs
and sheep to increase growth (Hammer et al., 1985). Since that time many other transgenic
animals including rabbits, sheep, pigs, and cattle have been produced.
Research involving transgenic livestock has the potential to provide enormous benefits to
animals as well as humans. By the insertion of genes, animals can be created that have increased
disease resistance (Cameron et al., 1994; Brem, 1993), can repel insects (Rollin, 1995 pg.171;
Robinson and McEvoy, 1993), produce higher quality food and medicinally valuable products
(Pursel and Rexroad, 1993; Ebert and Schindler, 1993), and have higher productivity (Pursel and
Rexroad, 1993). It would be especially beneficial to have cattle with such characteristics because
of the huge demand for their products (such as milk meat, and leather) and the potential to obtain
marketable amounts of protein products from the milk of high producing cattle.
Currently, in cattle, the process of producing transgenic animals is very inefficient. The
inefficiencies stem from mechanical or cytotoxic damage to the embryo due to microinjection,
failure of the cell to integrate the DNA, inability of the transferred embryo to survive to term,
failure of the gene to be in all cells of the animal's body, and failure to pass the gene on to
offspring (Wall and Seidel, 1992). Gibbons et al. (1995) reported that only about .02 to .2 % of
microinjected bovine embryos develop to term.
With regard to microinjection, inefficiencies stem from centrifugation of embryos to
visualize the pronuclei, decreased embryo viability after damage from the pronuclear injection,

and failure of the majority of transgenes to integrate into the embryo genome (Sparks et al.,
1994). After centrifugation, approximately 62% (Biery et al, 1988) to 72% (Sparks et al, 1994)
of the embryos have pronuclei that can be visualized well enough to do the microinjections. Of
the embryos microinjected, reported survival rates to the morula or blastocyst stage range from
5.2% (Han et al, 1996) to 45% (Sparks et al, 1994). These lowered embryo survival rates after
microinjection are thought by some to be due to damage to the pronucleus during the
microinjection procedure rather than due to general handling of the embryos or damage to
cytoplasmic components (Han et al, 1996). However, others have reported no difference in
developmental rates between cytoplasmically and pronuclearly injected embryos (Kubisch et al,
1995). Lysis of the cytoplasm or the pronucleus from the procedure has been implicated in the
loss ofup to 30% of injected embryos (Gibbons et al, 1995).
Finally, even if the embryo survives the microinjection process, researchers have not
demonstrated high rates of DNA integration. Kubisch et al. (1995) reports that cytoplasmically
injected bovine zygotes at the 4 and 8 cell stages allowed lower transgene incorporation rates
(8%) than those injected in the pronucleus (22.7%). In addition they found that after pronuclear
injection, two cell embryos had about 1-1.2 positive blastomeres per embryo, eight cell embryos
had an average of 1.8-2.9 positive blastomeres per embryo and 100% of the blastocyst stage
embryos were mosaic.
In light of the previous information, it seems that it would be very beneficial to try to
increase the efficiency of the microinjection process. As suggested by Dr. Ken White and Dr.
John Morrey, my senior project focuses on increasing microinjection efficiency by using nuclear
localization signals (NLS) connected to the transgene to allow for cytoplasmic injection.
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Cyoplasmic injection of DNA is a method worth pursuing because it would eliminate the
requirement for centrifugation of embryos to visualize pronuclei and possibly decrease the
embryo mortality due to pronuclear injection.
Although there have been other methods of cytoplasmic injection, including the use of
lysine to complex and condense DNA (Page et al., 1995), I will be using a method reported by
Collas et al. ( 1996), in which a nuclear localization signal from the SV40 T antigen is complexed
to the trans gene, directing it to the pro-nucleus of the zygote.
NLS sequences facilitate the passage of proteins and DNA in the natural state. It is a
sequence of amino acids, usually about 8-10 amino acids long that has a preponderance of
positively charged amino acids such as lysine and arginine next to a proline. The NLS can be
located at various sites within the targeted protein, and often is at multiple sites. It has been
found that the sequence is located on the outside of the secondary structure, the hydrophilic
region, of proteins that are taken into the nucleus. An increase in the number of localization
signals on a protein has been found to increase the uptake of the protein into the nucleus, so their
effects seem to be additive (Garcia-Bustos et al., 1991).
The nuclear pore complex is a multimeric protein with a mass of about 124 MDa
consisting of a fusion between the inner and outer nuclear membrane envelopes (Garcia-Bustos
et al., 1991). It is an 90 to 100 A aqueous channel that normally allows proteins and RNA up to
60 kDa to passively go through (Newmeyer and Forbes, 1988; Knauf et al., 1996). For larger
molecules containing a NLS, passage through the nuclear pore takes place in two general steps.
First, the NLS peptide binds to the pore protein, and then with the help of soluble mediators from
the cytoplasm, the molecule is taken into the nucleus through ATP dependent translocation
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(Knauf et al., 1996; Gorlich et al., 1995; Newmeyer and Forbes, 1988; Garcia-Bustos et al.,
1991).
Using these principles of nuclear localization, Collas et al. (1996) have incubated the
SV40 Tantigen peptide (sequence: PKKKRKV) with circular and linear DNA and based on gel
electrophoresis have found that it binds to the DNA through ionic interactions. Using this
complex injected into zebrafish embryos, they found that they could get results similar to
pronuclear injection with a 100 fold reduction in the DNA used in normal cytoplasmic injection.

Materials and Methods

Dissolving and testing the stability of the NLS peptide
SV40 T antigen NLS peptide of sequence CGGPKKKRKVG-NH2 (Collas et al., 1996)
with a molecular weight of 1157 g/mole was synthesized and purified by USU biotechnology
center. It was determined that to get in the range ofNLS:DNA of 1000: 1 as reported by Collas
et al. (1996), a protein concentration of approximately 3.8 ng/µl would be needed. For more
accurate measurement capabilities, a 2000X solution of the peptide was made (3.8 mg/ml). To
test the stability of the peptide, temperatures of -20°C, 4°C, and room temperature were used,
and samples were checked for pellet formations after 24 hours using centrifugation.

Preparation of DNA (pEGFP) MW

3102 KD

pEGFP DNA (Clonetech) was digested with Mlu I (Pharmacia) and run on a .8% agarose
gel ( 1X T AE) using lambda phage digested with Hind III as a marker to detect complete
digestion. Ethidium bromide stain was used to detect DNA on the gel. Digested DNA was
cleaned using Gene Clean (Bio 101). The same .8% agarose gel setup and detection methods
were used to analyze the effectiveness of the cleaning procedure.

DNA concentration determination
Since spectroscopy were not adequate in determining the concentration, it was found
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using DNA Dipstick

TM

(Invitrogen). Using the DNA dipstick, a comparison of the band

intensities on the gel electrophoresis of the cleaned DNA, and a standardized chart for the
concentration of Lambda Hind Ill, the concentration was found to be between 10-20 ng/ µl. For
further experiments, the concentration was assumed to be 15ng/µl.
Gel electrophoresis of NLS:DNA complexes for determination of DNA:Peptide binding
Using the molecular weights of DNA (3102 KD) and the protein ( 1157 D) a 1:1 molar
ratio is .0055935ng peptide for every 15 ng of DNA. To run the gel electrophoresis, 30 ng of
DNA was used in each mixture. The amount of protein used for each mixture was calculated
based on a concentration of 3.8 mg/ml, and the mass of peptide needed for each NLS:DNA molar
ratio. All NLS protein dilutions were done in loading buffer. The exact ratios that yielded
conclusive binding are as follows:
Molar ratio
(NLS:DNA)
lx106:1
100,000: 1
20,000:1
10,000:1
2,000:1

mass DNA

30 ng
30 ng
30 ng
30 ng
30 ng

volume DNA
(15ng/µl)
2ul
2 ul
2 ul
2 ul
2 ul

mass peptide

.01 lmg
.0011mg
.00022mg
.00011mg
2.2xl0 5mg

volume peptide
(3.8 mg/ml)
2.89ul of3.8 mg/ml
2.89 ul of 1:10 dilution
2.89 ul of 1:50 dilution
2.89 ul of 1:100 dilution
2.89 ul of 1:500 dilution

Embryo collection, maturation, andfertilization
A. Bovine: See Reed et al., Theriogenology 45:439-449
B. Mouse: See Reed et al., Transgenic Research 6: 340
Embryo culture and manipulation
A. Bovine: See also Reed et al., Theriogenology 45: 439-449.
HEPES media was used for manipulation of embryos. To 4 ml of TL HEPES, I added
120 mg BSA and filter sterilized to a total volume of 3 ml. This mixture was then added to 27
ml of sterile TL HEPES. The osmolarity of this media was around 265 for the bovine embryos.
30 ul of TL HEPES 3mg/ml BSA covered with mineral oil (Sigma) was used for
micromanipulation.
To culture the embryos, I used modified CR2 media, oviductal epithelial cells
(experiment 1,2), and dutch belted fetal fibroblasts (experiment 3). The embryos were initially
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incubated in a four well dish containing 400 µl of CR2 5%FBS in a 39°C, 5%CO 2 incubator. On
day 3 (day 1 is injection day), 200 ul of the culture media was removed and replaced with 200 ul
of 10 % FBS CR2. On approximately day 5, I removed 200 ul of media and replaced it with 250
ul 15% FBS CR2. 20% FBS CR2 media is added on day 7.
B. Mouse manipulation and culture
For manipulation and microinjection procedures, M2 was used. Culture of the mouse
embryos was done by using 50 ul drops of CZB (Chatot,et al., 1989) covered with mineral oil
(Sigma). They were then put into a satellite dish with an atmosphere of 5%02 , 5% CO 2 , 90%N 2
and incubated at 37°C. After 48 hours, the embryos were switched to CZB containing 5.5mM
glucose in the same atmospheric conditions and temperature.
Micromanipulation tools

Holders were made by pulling thin glass capillaries with no filament (1.00 mm diameter)
to a point and using a microforge to break the tip evenly at an outside diameter of 120-130 um
for bovine embryos and about 90 um for mouse embryos. The tips were ground with a diamond
dust grinder and the holders washed once in HF and three times in purified water to get rid of any
glass fragments. Finally, after the holder was dry, I polished the tip and bent it to a 30 degree
angle with a microforge.
Microinjection needles for the cytoplasmic injection of bovine embryos (thin walled
borosilicate glass capillaries with a filament: World Precision Instruments) were pulled using a
flaming brown puller (Sutter Instruments) at settings of program 2 *, pressure 102 (experiments
1,2) and pressure 92 (experiment 3). For the mouse embryos, program 2, pressure 102 (1) and
pressure 92 (2) was used.
*program two parameters:

heat
670
680

pull
80
100

velocity
20
50

time
95
120

Detection of Fluorescence
An inverted microscope equipped with epifluorescent capabilities and illuminated with a

xenon light source* passed through a green fluorescent specific filter set was used to identify
embryos that expressed the transgene.
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*Xenon light source on Nikon Diaphot microscope, 10 X fluor objective. Filter set: excitation:
480 DF 30 (Omega Optical) Mirror: 505 DR LP (Omega) Emition: HQ 510 LP (Chroma
Technologies)
Results

Stability of SV40 T antigen
Temperature
Pellet after centrifugation
-20 C
N
4C
N
Room Temp
N
Gel of Cleaned DNA sample

Binding of Nuclear Localization Signal Peptide to pEGFP

Lane 8
Lane 7
Lane 6
Lane 5
Lane 4
Lane 3
Lane 2
Lane 1

DNA only
NLS peptide only
1,000,000: 1
100,000: 1
20,000:1
10,000: 1
2,000:1
Lambda Hind III

From this gel, it can be seen that the retardation of the NLS-DNA complexes becomes most
prominent at 100,000: 1. At this level there is a diffuse band with a small area that is
concentrated. It is possible that this resulted from complexes of many sizes being formed. There
is also some retardation at the 20,000: 1 level.
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Bovine culture andfluorescence data
Maximum developmental stage reached in vitro
Total # 2 cell 4cell 8cell 16cell morula blastocyst fluorescence
Experiment 1
Treatment
1
1
3- 1blastocyst
NLS:DNA 25
1
3
(20,000:1)
1
buffer
23
3
0
Control10
1 deg.
noninjected*
Experiment 2
Treatment
6 +3?
NLS:DNA
15
(20,000:1)
2+1?
DNA
15
1+3?
Control20
noninjected
Experiment 3
Treatment
NLS:DNA
44
5
6
5
(20,000:1)
1
1 bright one celled
NLS:DNA 35
1
3
(2,000:1)**
2 bright one celled
NLS:DNA 49
4
1
8
(200: 1)
1 deg
Control
50
7
7
3
1
- noninjected
*note: control group small because of handling problems; development low probably because of
poor handling of this group
**note: this group was out of the incubator the longest because of microinjection needle
difficulties
Mouse culture and fluorescence data
Total number Uncleaved Multicell Blastocyst Fluorescence
Experiment 1
Treatment
18 (64%)
1 fragmented;
NLS:DNA
28
2
6
1 uncleaved
(20,000:1)
14 (40 %)
NLS
35
2
17
23 (63.8%)
DNA
36
4
8
16 (80%)
Buffer
20
1
2
Culture Controls
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Always in incubator
In culture at end of
manipulations
In culture at beginning
of manipulation
Total Number
Experiment 2
Treatment
NLS:DNA
(2000:1)
NLS:DNA
(20,000:1)
NLS:DNA
(1/10 of
20,000:1)
Noninjected
Controls

23
14
20

8
3

13 (56.5%)
11 (78.6%)

5

10 (50.0%)

2

B lastocyst (Grade)

%Blast

Fluorescence

7 (1,2);
1 (3); 1hatched
3 (1,2);
2 (3,4)

66.7%

1 bright blastocyst

33.3%

15

5

33.3%

degenerating embryo
with one intact
fluorescent blastomere
1 weakly fluorescent
(?) blastocyst

16

7 (1,2)
3 (3,4)

62.5%

12
15

Discussion
From this data, I cannot conclude, either positively or negatively whether or not using

cytoplasmic injection of SV40 T antigen NLS sequence complexed to DNA increases the
efficiency of creating transgenic embryos. This mainly stems from the fact that the number of
embryos in my treatment groups and the number that developed to blastocyst was low in my
experiment. By increasing the number of embryos that are able to make it to the blastocyst stage,
a more accurate conclusion about the efficiency of the protein could be made. My experiments
do provide some useful information about the protein, however. First of all, it does not seem to
be toxic to embryos since a general trend of decreased viability is not seen when compared with
DNA only injections and noninjected controls. However, mouse experiment two showed a
fluorescent blastocyst and increased development with a lower protein: DNA ratio indicating that
possibly the protein was more efficient at this level. Secondly, it can be concluded that the
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protein is actually integrating the protein into the embryos genome. This is because the
blastocysts that showed fluorescence only did so upon reaching the blastocyst stage. In previous
developmental stages, no fluorescence was detected, leading me to the conclusion that the
fluorescence seen was not just transient cytoplasmic expression. Finally, it seems that there are
activities of the protein in relation to the development of mammalian embryos that are yet to be
delineated since we have found a couple of one celled zygotes to have been brightly fluorescent.
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